Alume Biosciences Appoints Rick Gonzalez as Chief Commercial Officer
13 Sep 2024 //
PR NEWSWIRE
Alume Biosciences Secures $13 M In Series B Financing
10 Jan 2023 //
PR NEWSWIRE
Alume Biosciences Begins Dosing of ALM-488 in PIII Pivotal Study
23 Aug 2022 //
PRNEWSWIRE
Alume Biosciences Granted FDA Fast Track Designation Of ALM-488
11 May 2021 //
PRNEWSWIRE